都柏林ISUP共识:脐尿管肿瘤病理实践推荐
2023年都柏林ISUP共识会议针对罕见脐尿管肿瘤缺乏结构化病理推荐的问题,由80名参与者达成共识,提出10条关于脐尿管癌诊断、大体检查、取材、免疫组化、分类及分期的实践推荐,旨在指导病理医师报告并推动标准化研究。
要点
- 脐尿管癌诊断需结合大体、组织学、临床及影像并排除转移。
- 应应用2022年WHO分别针对脐尿管腺癌和非腺性癌的诊断标准。
- 反对对低度恶性潜能黏液性囊性肿瘤的腔内癌范围使用5%或10% cutoff。
核心结论
- 共识为脐尿管肿瘤病理提供实践推荐,涵盖诊断、取材、分类和分期。
- 建议设计新的脐尿管癌分期方法,并研究改良膀胱癌TNM/AJCC分期系统。
研究设计与样本
- 2023年都柏林ISUP共识会议,80名参与者达成共识。
主要发现
- 共识涉及10条推荐,包括诊断需排除转移、应用2022 WHO标准、大体检查要素、取材建议、反对特定cutoff、免疫组化可选、非腺性癌分类规则、分期建议及报告要素。
关键数值与推荐
- 诊断脐尿管癌需结合大体、组织学、临床和影像学,并排除继发性转移。
- 应应用2022 WHO分别针对脐尿管腺癌和非腺性癌的诊断标准。
- 反对对脐尿管低度恶性潜能黏液性囊性肿瘤的腔内癌范围使用5%或10% cutoff。
- 经尿道切除标本中免疫组化标记用于脐尿管腺癌鉴别诊断被视为可选。
- 非腺性脐尿管癌应应用膀胱黏膜起源癌(如尿路上皮癌、鳞状细胞癌和神经内分泌癌)的类似分类规则。
临床怎么用
- 病理医师可依据共识进行脐尿管肿瘤的大体检查、取材和报告。
- 共识可作为未来标准化报告方案和研究的指南。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This manuscript summarizes the first part of the proceedings of the 2023 Dublin ISUP Consensus Conference encompassing the best practice recommendations on the pathology of neoplasms of urachal origin. The rationale for convening this consensus conference was the lack of structured and consented histopathologic recommendations in these rare tumors. Consensus among the meeting participants (n=80) was reached on the following statements: (1) combination of gross, histologic, clinical and imaging findings with exclusion of secondary tumor metastasis are to be used in the diagnosis of urachal carcinoma; (2) the 2022 World Health Organization (WHO) separate criteria for the diagnosis of urachal adenocarcinoma and for nonglandular carcinoma should be applied; (3) specific elements are to be evaluated and recorded in the gross examination of resection specimens containing urachal tumors; (4) sampling considerations for resection specimens containing urachal tumors are advised; (5) participants are against using 5% or 10% cutoff for the extent of intraepithelial carcinoma in urachal mucinous cystic tumor of low malignant potential; (6) use of immunohistochemical markers for the differential diagnosis of urachal adenocarcinomas in transurethral resection (TUR) specimen is considered optional; (7) similar tumor classificatory (nosology) rules for carcinomas arising from bladder mucosa (eg, urothelial carcinoma, squamous cell carcinoma, and neuroendocrine carcinoma) should be applied for nonglandular urachal carcinomas; (8) a new staging approach other than the previously proposed systems should be designed for urachal carcinoma; (9) a system modifying the current Tumor-Node-Metastasis (TNM)/American Joint Committee on Cancer (AJCC) staging system for urinary bladder cancer is considered appropriate for a study in urachal carcinoma; and (10) several histologic elements are to be reported when diagnosing urachal carcinoma in TUR and resection specimens. This report from the Dublin ISUP consensus conference will serve as a practice recommendation for pathologists and as a guide for future standardized reporting protocols and research regarding urachal tumors. In addition, an international database for urachal cancers under the guidance of ISUP is being planned to be established to address pertinent issues in the pathology of urachal cancers.
引用
- Reis H, Al-Ahmadie H, Gaisa NT, et al. The Dublin International Society of Urological Pathology (ISUP) Consensus Conference on Best Practice Recommendations on the Pathology of Urachal Neoplasms. Am J Surg Pathol. 2025. PMID: 40471793. doi:10.1097/PAS.0000000000002416
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。